BREXIT has led to Human Tissue Authority (HTA) regulatory changes that could affect some UK dental providers.
Most specifically, if a dental contractor imports or exports human tissues and cells between GB and a country in the EEA for human application this may require an HTA licence as of 1 July 2021.
Some products used in the placement procedure of dental implants are examples of relevant human tissue. Products may include:
- cancellous bone particles
- demineralised bone matrix (DBM)
- DBM putty
- pericardium
- skin and dermal tissue products.
The regulatory changes do not apply to organisations in GB (England, Scotland and Wales) ordering human tissues and cells from suppliers in the UK already licensed by the HTA.
Dental contractors who think their practice might be affected by these changes can visit the HTA website.
You can also contact the HTA directly for advice on enquiries@hta.gov.uk.
This page was correct at the time of publication. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.
Save this article
Save this article to a list of favourite articles which members can access in their account.
Save to library